VCEL240517P55000
- 6.30
- 0.000.00%
Vericel Newsroom
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President
Vericel(VCEL.US) Officer Sells US$499.9K in Common Stock
$Vericel(VCEL.US)$ Officer Hopper Jonathan Mark sold 10,000 shares of common stock on May 20, 2024 at an average price of $49.99 for a total value of $499.9K.Source: Announcement What is statement of
Vericel Insider Sold Shares Worth $499,900, According to a Recent SEC Filing
Jonathan Mark Hopper, Chief Medical Officer, on May 20, 2024, sold 10,000 shares in Vericel (VCEL) for $499,900. Following the Form 4 filing with the SEC, Hopper has control over a total of 58,116 sha
Form 144 | Vericel(VCEL.US) Officer Proposes to Sell 482.6K in Common Stocks
SEC FILLINGS DISCLOSED/ May 20, $Vericel(VCEL.US)$ Officer Hopper Jonathan Mark intends to sell 10,000 shares of its common stock on May 20, with a total market value of approximately $482.6K. Sour
Vericel(VCEL.US) Officer Sells US$1.71 Million in Common Stock
$Vericel(VCEL.US)$ Officer Colangelo Dominick sold 35,000 shares of common stock on May 15, 16, 2024 at an average price of $48.76 for a total value of $1.71 million.Source: Announcement What is state
Form 144 | Vericel(VCEL.US) Officer Proposes to Sell 861K in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Vericel(VCEL.US)$ Officer Colangelo Dominick intends to sell 17,500 shares of its common stock on May 16, with a total market value of approximately $861K. Colangelo
Form 144 | Vericel(VCEL.US) Officer Proposes to Sell 863.1K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Vericel(VCEL.US)$ Officer Colangelo Dominick intends to sell 17,500 shares of its common stock on May 15, with a total market value of approximately $863.1K. Colange
Vericel's Strong Q1 Performance and Growth Potential Affirm Buy Rating
Critical Insights From Vericel Analyst Ratings: What You Need To Know
Throughout the last three months, 4 analysts have evaluated Vericel (NASDAQ:VCEL), offering a diverse set of opinions from bullish to bearish.The table below offers a condensed view of their recent ra
Vericel Corporation (NASDAQ:VCEL) Q1 2024 Earnings Call Transcript
Vericel Is Maintained at Buy by HC Wainwright & Co.
Vericel Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $55
Vericel Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 13.72% HC Wainwright & Co. $53 → $55 Maintains Buy 03/26/2024 11.65% Truist Securities $54 → $5
Express News | Vericel Corporation : H.c. Wainwright Raises Target Price to $55 From $53
Vericel Corp (VCEL) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...
Express News | Vericel Corp : Stephens Raises Target Price to $56 From $54
Q1 2024 Vericel Corp Earnings Call
Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript
Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript
Vericel Corp (VCEL) Surpasses Q1 Revenue Forecasts With Strong Growth in Core Markets
Vericel Q1 Loss Narrows, Revenue Increases; 2024 Outlook Lifted -- Shares Rise Pre-Bell
Vericel (VCEL) reported a Q1 loss Wednesday of $0.08 per diluted share, narrowing from a loss of $0.16 a year earlier. Analysts polled by Capital IQ expected a loss of $0.11. Revenue for the quarter e